DOI QR코드

DOI QR Code

A Case of Ticagrelor Rescue Therapy in a Patient with Subacute Stent Thrombosis

아급성 관상동맥 스텐트 혈전증에서 Ticagrelor를 사용한 1예

  • Ko, Jun Kwon (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Kim, Ji Soong (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Chung, Sung Jun (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Kim, Seong Jong (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Kim, Byung Sihk (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Kim, You Shin (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Shin, Jeong Hun (Departments of Internal Medicine, Hanyang University College of Medicine)
  • 고준권 (한양대학교 의과대학 내과학교실) ;
  • 김지숭 (한양대학교 의과대학 내과학교실) ;
  • 정승준 (한양대학교 의과대학 내과학교실) ;
  • 김성종 (한양대학교 의과대학 내과학교실) ;
  • 김병식 (한양대학교 의과대학 내과학교실) ;
  • 김유신 (한양대학교 의과대학 내과학교실) ;
  • 신정훈 (한양대학교 의과대학 내과학교실)
  • Received : 2014.10.13
  • Accepted : 2014.02.24
  • Published : 2014.11.01

Abstract

Stent thrombosis (ST) is a rare but catastrophic complication of a drug-eluting stent. Although dual antiplatelet therapy with aspirin and clopidogrel significantly reduces the occurrence of ST, it continues to occur and is occasionally associated with clopidogrel resistance. Here, we describe a 71-yr-old man with subacute stent thrombosis and clopidogrel resistance following drug-eluting stent implantation who underwent successful ticagrelor rescue therapy.

뇌졸중으로 아스피린과 클로피도그렐을 복용하던 71세 남자 환자에서 급성 하벽 심근경색증으로 관상동맥 중재술을 시행하였다. 시술 7일째 급성 호흡곤란 및 ST분절 상승소견으로 시행한 관상동맥 조영술에서 스텐트 혈전증을 진단 후 중재술을 시행하였다. 혈소판 기능 검사에서 Clopidogrel 저항성이 확인하였고 뇌졸중 과거력을 고려해 Ticagrelor로 구조요법(rescue therapy)을 시행한 증례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

Keywords

References

  1. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-425. https://doi.org/10.1161/CIR.0b013e3182742cf6
  2. Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-3175. https://doi.org/10.1161/01.CIR.0000130846.46168.03
  3. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246-251. https://doi.org/10.1016/j.jacc.2004.09.067
  4. Bonello L, Tantry US, Marcucci R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010;56:919-933. https://doi.org/10.1016/j.jacc.2010.04.047
  5. Kim IS, Choi BR, Jeong YH, Kwak CH, Kim S. The CYP2C19*2 and CYP2C19*3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome. J Thromb Haemost 2009;7:897-899. https://doi.org/10.1111/j.1538-7836.2009.03319.x
  6. Park KW, Kim HS. Stent thrombosis in the DES era. Korean J Med 2008;75:383-391.
  7. Geisler T, Zurn C, Simonenko R, et al. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions. Eur Heart J 2010;31:59-66. https://doi.org/10.1093/eurheartj/ehp402
  8. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-2015. https://doi.org/10.1056/NEJMoa0706482
  9. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057. https://doi.org/10.1056/NEJMoa0904327
  10. Kang MK, Chang K. New oral antiplatelet agents. Korean J Med 2013;85:10-14. https://doi.org/10.3904/kjm.2013.85.1.10